HIV-1 gp120
Local Conformational Stability of HIV-1 gp120 in Unliganded and CD4-Bound States as Defined by Amide Hydrogen/Deuterium Exchange
11
The HIV-1 gp120 Major Variable Regions Modulate Cold Inactivation
9
Synthetic multimeric peptides derived from the principal neutralization domain (V3 loop) of human immunodeficiency virus type 1 (HIV-1) gp120 bind to galactosylceramide and block HIV-1 infection in a human CD4-negative mucosal epithelial cell line.
6
Human CNS cultures exposed to HIV-1 gp120 reproduce dendritic injuries of HIV-1-associated dementia
9
Extracellular Matrix Proteins Mediate HIV-1 gp120 Interactions with α4β7
26
Antioxidant protection from HIV-1 gp120-induced neuroglial toxicity
14
Allosteric induction of the CD4 bound conformation of HIV 1 Gp120
16
Human Erythrocyte Glycosphingolipids as Alternative Cofactors for Human Immunodeficiency Virus Type 1 (HIV-1) Entry: Evidence for CD4-Induced Interactions between HIV-1 gp120 and Reconstituted Membrane Microdomains of Glycosphingolipids (Gb3 and GM3)
5
Isolate-Specific Differences in the Conformational Dynamics and Antigenicity of HIV-1 gp120
19
Conformational alterations in the CD4 binding cavity of HIV 1 gp120 influencing gp120 CD4 interactions and fusogenicity of HIV 1 envelopes derived from brain and other tissues
10
Staphylococcus aureus Leukocidin LukED and HIV 1 gp120 Target Different Sequence Determinants on CCR5
11
Differences in the mannose oligomer specificities of the closely related lectins from Galanthus nivalis and Zea maysstrongly determine their eventual anti HIV activity
16
Use of silver nanoparticles increased inhibition of cell-associated HIV-1 infection by neutralizing antibodies developed against HIV-1 envelope proteins
9
Release of gp120 Restraints Leads to an Entry Competent Intermediate State of the HIV 1 Envelope Glycoproteins
12
HLA C increases HIV 1 infectivity and is associated with gp120
15
Molecular mimicry between the human immunodeficiency virus type 1 gp120 V3 loop and human brain proteins.
5
A Replication-Competent, Neutralization-Sensitive Variant of Simian Immunodeficiency Virus Lacking 100 Amino Acids of Envelope
12
Discovery of Small-Molecule Human Immunodeficiency Virus Type 1 Entry Inhibitors That Target the gp120-Binding Domain of CD4
12
Human Immunodeficiency Virus Type 1 Uses Lipid Raft-Colocalized CD4 and Chemokine Receptors for Productive Entry into CD4+ T Cells
14
HIV 1 envelope, integrins and co receptor use in mucosal transmission of HIV
10